documents: DEA-2022-0068-0005
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEA-2022-0068-0005 | DEA | DEA-2022-0068 | FINAL SIGNED - Fenfluramine Letter and 8FA review 16Apr2021 | Supporting & Related Material | 2023-01-03T05:00:00Z | 2023 | 1 | 2023-01-03T13:21:30Z | 0 | 0 | 090000648557e6b8 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref